A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Japanese Experience ◽

Phase Ii Clinical Study ◽

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: A Japanese experience

Surgery Today ◽

10.1007/s00595-010-4418-6 ◽

2010 ◽

Vol 41 (1) ◽

pp. 84-90

Author(s):

Yutaka Ogata ◽

◽

Shoji Tokunaga ◽

Yasunori Emi ◽

Eiji Oki ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Study ◽

Folinic Acid ◽

Combination Chemotherapy ◽

Line Treatment ◽

Second Line ◽

Multicenter Phase ◽

Japanese Experience ◽

Phase Ii Clinical Study

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

The Lancet Oncology ◽

10.1016/s1470-2045(11)70102-4 ◽

2011 ◽

Vol 12 (7) ◽

pp. 642-653 ◽

Cited By ~ 169

Author(s):

Richard A Adams ◽

Angela M Meade ◽

Matthew T Seymour ◽

Richard H Wilson ◽

Ayman Madi ◽

...

Keyword(s):

Colorectal Cancer ◽

Combination Chemotherapy ◽

Line Treatment ◽

First Line ◽

Phase 3 ◽

Bevacizumab + folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (prot. GOIM 2601)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15048 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15048-15048

Author(s):

G. Colucci ◽

F. Giuliani ◽

V. Lorusso ◽

F. De Vita ◽

S. Cinieri ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Randomized Multicenter Phase II Trial of Oxaliplatin Plus Irinotecan Versus Raltitrexed as First-Line Treatment in Advanced Colorectal Cancer

Journal of Clinical Oncology ◽

10.1200/jco.20.1.165 ◽

2002 ◽

Vol 20 (1) ◽

pp. 165-172 ◽

Cited By ~ 22

Author(s):

W. Scheithauer

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)

European Journal of Cancer Supplements ◽

10.1016/j.ejcsup.2008.06.042 ◽

2008 ◽

Vol 6 (14) ◽

pp. 121

Author(s):

F. Giuliani ◽

V. Lorusso ◽

F. De Vita ◽

S. Cinieri ◽

E. Maiello ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Faculty Opinions recommendation of Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958548.793464802 ◽

2012 ◽

Author(s):

Yiqian Nancy You ◽

Brian Keith Bednarski

Keyword(s):

Colorectal Cancer ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Double Blind ◽

Phase Iii Study ◽

Treatment breaks in first line treatment of advanced colorectal cancer: an individual patient data meta-analysis

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2021.102226 ◽

2021 ◽

pp. 102226

Author(s):

Richard Adams ◽

Kaitlyn Goey ◽

Benoist Chibaudel ◽

Miriam Koopman ◽

Cornelis Punt ◽

...

Keyword(s):

Colorectal Cancer ◽

Individual Patient Data ◽

Meta Analysis ◽

Patient Data ◽

Line Treatment ◽

First Line ◽

Prevention of irinotecan plus5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer

Annals of Oncology ◽

10.1093/annonc/mdg193 ◽

2003 ◽

Vol 14 (5) ◽

pp. 805 ◽

Cited By ~ 26

Author(s):

A. Alimonti ◽

F. Satta ◽

I. Pavese ◽

E. Burattini ◽

V. Zoffoli ◽

...

Keyword(s):

Colorectal Cancer ◽

Oral Administration ◽

Line Treatment ◽

First Line ◽

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2014.12.020 ◽

2015 ◽

Vol 51 (4) ◽

pp. 473-481 ◽

Cited By ~ 10

Author(s):

Maria Di Bartolomeo ◽

Andrea Ciarlo ◽

Alessandro Bertolini ◽

Sandro Barni ◽

Claudio Verusio ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Medical Oncology ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First-line treatment with modified FOLFOXIRI plus bevacizumab in patients with locally advanced colorectal cancer

Annals of Cancer Research and Therapy ◽

10.4993/acrt.28.44 ◽

2020 ◽

Vol 28 (1) ◽

pp. 44-48 ◽

Cited By ~ 1

Author(s):

Yasufumi Yamada ◽

Kazuhiko Yoshimatsu ◽

Hajime Yokomizo ◽

Sachiyo Okayama ◽

Hiroyuki Maeda ◽

...

Keyword(s):

Colorectal Cancer ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Locally Advanced Colorectal Cancer ◽